MIRA
INFORM REPORT
|
Report Date : |
14.06.2008 |
IDENTIFICATION
DETAILS
|
Name : |
HOSPIMEDICA INTERNATIONAL PRIVATE LIMITED |
|
|
|
|
Registered Office : |
58/10, Leelawanti House, Ashok Nagar, New Delhi – 110018 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
16.01.1997 |
|
|
|
|
Com. Reg. No.: |
55-84505 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U51507DL1997PLC084505 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
DELH02216E |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Importers, Distributors and Suppliers of Medical Equipments. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 216695 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well
– established company having satisfactory track. Trade relations are fair.
General financial position is satisfactory. Payments are usually correct and
as per commitments. The company can
be considered normal for business dealings at usual trade terms and
conditions. |
LOCATIONS
|
Registered Office : |
58/10, Leelawanti House, Ashok Nagar, New Delhi – 110018, India |
|
Tel. No.: |
91-11-25400984/ 25146164/ 25146165 |
|
Fax No.: |
91-11-25492977/ 25138164 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
15,000 Sq.ft (It is a 3-storey building owned by the subject) |
|
Location : |
Commercial |
|
|
|
|
Sales
Office: |
Bangalore Mr R G Kulkarni, House No. 27, Shree Nivasa, Nagarbhavi Road, Gangadhar
Layout, Vijay Nagar, bangalore 560 040 Mobile – 91- 9342502115 Chandigath House No. 1698, Phase - III, B-2 Mohali, Chandigarh 160 059 Mobile - 91 -9316519854 Chennai Sarada Nilayam No. 3, 26th Street, Asthalakshmi Nagar, Allapakkam,
Chennai 600 116 Mobile - 91- 9382785570 Indore 359/A, Mahalaxmi Nagar, Opp. Bombay Hospital, Ring Road, Indore 452010 Mobile - 91- 9302136827 Kolkata 18/8, B M Debya Road, Kolkata 700 061 Phone - 91- 33 2493 5761 Mumbai C-3 Vireshwar Sneh, Sant Janabai Road, Dixit Road Extension, Vile Parle
(East), Mumbai 400 057 Phone - 91- 9322302152 Fax - 91- 22- 2610 6740 Pune Disney Park, Survey No. 58/6, Building - H, Flat No. 19, Wanda Worrie,
Pune 411 022 Phone - 91 -9325503074 Trivandrum Hamilton & Bailey, Pallottigiri Building, Opp. Margin Free Market,
Medical College, P.O. Trivandrum, Kerala Phone - 91 -9388485329 |
|
|
|
|
Branches : |
Located At: v
Mumbai v
Kolkata v
Chennai v
Lucknow |
DIRECTORS
|
Name : |
Mr. Sunil Anand |
|
Designation : |
Managing Director
/ Chairman |
|
Address : |
58/10, Third Floor,
Ashok Nagar, New Delhi 110 018, India |
|
Date of Birth/Age : |
06.04.1960 |
|
Qualification : |
Graduate in
Electronic Engineering |
|
Date of Appointment : |
16.01.1997 |
|
|
|
|
Name : |
Mr. Sanjeev Anand |
|
Designation : |
Director |
|
Address : |
4B/27, Tilak
Nagar, New Delhi 110 018, India |
|
Date of Birth/Age : |
03.07.1964 |
|
Date of Appointment : |
16.01.1997 |
|
|
|
|
Name : |
Ms. Meeta Anand |
|
Designation : |
Director |
|
Address : |
58/10, Third
Floor, Ashok Nagar, New Delhi 110 018, India |
|
Date of Birth/Age : |
29.07.1967 |
|
Date of Appointment : |
16.01.1997 |
KEY EXECUTIVES
|
Name : |
M/s Suresh K
Meher & Associates |
|
Designation : |
Company Sectary |
|
Address : |
39 DDA (LIG) Flats,
Motia Khan, Pahar Ganj, New Delhi 110 055 |
|
E-mail : |
|
|
|
|
|
Name : |
Mr. O P Anand |
|
Designation : |
General Manager
(Admin) |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
As on 30.09.2004
|
Names of Shareholders |
No. of Shares |
|
Mr. Sunil Anand |
311,645 |
|
Mr. Sanjiv Anand |
69,644 |
|
Ms Meeta Anand |
12,215 |
|
Mr. Rajinder
Kumar |
10 |
|
Mr. Sushil Anand |
10 |
|
Ms Dolly Aggarwal |
10 |
|
Mr. Bhim Arora |
10 |
|
Ms Mamla Rani |
10 |
|
Ms Sarla Arora |
10 |
|
Ms Ritika Kapoor |
10 |
|
M/s Sanjeev
Anand, HUF |
4,160 |
|
Ms Bharti Anand |
11,000 |
|
Ms Anju Garg |
1 |
|
M/s Sani Sales
India Pvt Ltd |
50,000 |
Equity share breakup (Percentage of total equity)
As on 31.03.2007
|
Sr. No. |
Category |
Percentage |
|
1. |
Bodies corporate (not mentioned above) |
22.70 |
|
2. |
Directors or relatives of directors. |
77.30 |
|
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Importers, Distributors and Suppliers of Medical Equipments. |
|
|
|
|
Products : |
Anaesthesiology/OT
Products v Ascepticization Equipment v Monitors for ICU, CCU v O.T. Lights v O.T. Tables v Patient Simulation v Patient Warming System v Recovery Room Monitors Blood Bank v Blood Collection Scale/Mixer v Donor Couch v Tube Sealers Burns/Plastic
Surgery v Burn Treatment Gel/Solution v Hyperbaric Chambers Central
Sterile Supplies v Bulk Steam Steriliser v Waste Steriliser cum Shredder ENT v Air/Water Caloric Stimulators v Balance Assessment System v BERA Equipment v ENG/VNG Equipment v Facial Nerve Monitor v Sleep/Apnea Analysis Equipment Hospital Furniture v Beds v Patient Trolleys Hospital Waste
Management v Cremation Furnaces v Incinerators v Integrated Shredder and Steriliser Neuro Sciences v ASA v Cognitrace v Digital EEG System v Intra Operative Never Monitors v Magnetic Stimulators v Polysomnography System v RF Pain Management Generator v Thermal Sensory Analyser Obstetrics v Female Sexual Dysfunction Monitor v Incontinence Diagnostic & Therapy
Equipment v Obstetric & Gynaecology Chair/Bed PT / Physical Medicine v Back Care System v Body Composition Analyser v CAD CAM Equipment v Casual Treatment v Holistic Medicine Equipment v Combination Therapy v CPM Equipment for Upper/Lower Limbs v Electric High Power Massager v EMG Biofeedback v Ergometers/Exercise Cycles v Fall Risk Assessment v Foot Pressure Distribution Assessment
System v Functional Electrical Simulator v Gait/Motion Analysis System v Hydro Therapy Equipment v Isokinetic Systems v Laser Therapy Units v Ultrasound Therapy v Microwave Therapy v Magnetic Therapy Equipment Paediatrics v Deflux v Vital Sign Monitor Psychiatry v EEG/ERP System v Digital EEG System v ECT Machine v Polysomnography System v Transcranial Magnetic Stimulator Rescue/Fire Disaster Management v Ambulance Trolley Stretchers v Burn Treatment Gel/Solution v Leg Injury Simulator v Splints v Stretchers Urology v Cryotherapy Equipment v Deflux v Holmium Laser v PSA Detection Kit v PVP Green Light Laser for Treatment of
Prostate v Test Kit for Bladder Cancer v Uroflowmetry Equipment v Urodynamics Equipment |
|
|
|
|
Agencies Held : |
v Enraf Nonius B. V., The Netherlands v Medelec Limited, U.K. v Merivaara Instrumentation Corporation,
Finland v Collin Corporation, Japan v Reimers and Jannsen GmbH, Germany |
|
|
|
|
Exports : |
|
|
Countries : |
India |
|
|
|
|
Imports : |
|
|
Products : |
Medical Equipments |
|
Countries : |
v
Japan v
USA v
Germany v
France v
Netherlands v
UK v European countries |
|
|
|
|
Terms : |
|
|
Selling : |
Cash, L/C or
Credit (60 days) terms |
|
|
|
|
Purchasing : |
L/C |
GENERAL
INFORMATION
|
Customers : |
v
Wholesalers v
Retailers v Government Bodies Major Customers v All India Institute of Medical Sciences,
New Delhi, India v G. B. Pant Super Speciality Hospital, New
Delhi, India. v Postgraduate Institute of Medical
Education and Research, India v Bombay Hospital, Mumbai, Maharashtra,
India |
|
|
|
|
No. of Employees : |
100 |
|
|
|
|
Bankers : |
v Punjab and Sind Bank, Maya Puri, New Delhi
- 110 064, India v State Bank of
India, Tilak Nagar, New Delhi -
110 064, India |
|
|
|
|
Facilities : |
Agreement of
Hypothecation of Goods to Secure a Demand Cash Credit Rs. 0.700 Millions with
Punjab & Sind Bank Cash Credit
facilities: Rs.13.500 Millions with State Bank of India, Tilak Nagar, New
Delhi Bank Agreement dated 26th October, 2004 and it is secured by
First charge on entire Currents Assets of the Company including medical
equipments, goods-in-transit, receivables of the Company and Equitable
Mortgage of Property situated at 4B/27 Tilak Nagar, New Delhi 110 018 in the
Name of Shri Sanjeev Anand. Equitable
Mortgage of Flat No. C-3, Vireshwar
Shah, Sant Janabi Road, Dixit Road Extn., Vile Parle (East) Mumbai in the
name of Mr. Sunil Anand. Assignment
of LIC policies in the name of Mr. Sunil Anand & Mrs. Meeta Anand and
Personal Guarantee of Mr. Sunil Anand, Mr. Sanjeev Anand and Mrs. Meeta Anand |
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
M/s Bhupesh Dhingra & Company Chartered Accountant |
|
Address : |
604 Padma Tower – II, Rajendra Place, New Delhi 110 008 |
|
Tel. No.: |
91-11-2572 4472 |
|
Fax No.: |
91-11-2574 2707 |
|
|
|
|
Associates/Subsidiaries : |
Medical Point
India Private Limited |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1,000,000 |
Equity Shares |
Rs.10/- each |
Rs. 10.000
millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
528,701 |
Equity Shares |
Rs.10/- each |
Rs. 5.287
millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
5.287 |
4.695 |
4.587 |
|
|
2] Share Application Money |
0.208 |
9.701 |
0.000 |
|
|
3] Reserves & Surplus |
37.844 |
7.677 |
1.777 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
43.339 |
22.073 |
6.364 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
3.244 |
3.737 |
6.624 |
|
|
2] Unsecured Loans |
1.000 |
1.000 |
1.000 |
|
|
TOTAL BORROWING |
4.244 |
4.737 |
7.624 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
47.583 |
26.810 |
13.988 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
8.866 |
5.779 |
3.724 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.052 |
0.048 |
0.005 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
37.749
|
42.922 |
24.697 |
|
|
Sundry Debtors |
37.825
|
17.420 |
10.528 |
|
|
Cash & Bank Balances |
19.752
|
13.394 |
3.649 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
7.756
|
9.088 |
5.766 |
|
Total
Current Assets |
103.082
|
82.824 |
44.640 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
63.639
|
60.755 |
33.755 |
|
|
Provisions |
0.822
|
1.144 |
0.650 |
|
Total
Current Liabilities |
64.461
|
61.899 |
34.405 |
|
|
Net Current Assets |
38.621
|
20.925 |
10.235 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.042 |
0.059 |
0.024 |
|
|
|
|
|
|
|
|
TOTAL |
47.583 |
26.810 |
13.988 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
Sales Turnover |
84.669 |
49.674 |
25.229 |
|
|
Other Income |
26.108 |
11.074 |
13.306 |
|
|
Total Income |
110.777 |
60.748 |
38.535 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
2.829 |
2.265 |
0.752 |
|
|
Provision for Taxation |
1.658 |
1.165 |
0.000 |
|
|
Profit/(Loss) After Tax |
1.171 |
1.100 |
0.752 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Purchases made for re-sale |
38.234 |
48.487 |
15.807 |
|
|
Increase/(Decrease) in Finished Goods |
(5.172) |
18.225 |
0.000 |
|
|
Salaries, Wages, Bonus, etc. |
8.253 |
5.672 |
3.947 |
|
|
Managerial Remuneration |
1.650 |
1.010 |
0.000 |
|
|
Payment to Auditors |
0.112 |
0.061 |
0.028 |
|
|
Interest |
0.990 |
1.166 |
0.000 |
|
|
Insurance Expenses |
0.293 |
0.147 |
0.000 |
|
|
Depreciation & Amortization |
1.498 |
0.995 |
0.858 |
|
|
Other Expenditure |
62.090 |
(17.280) |
17.143 |
|
Total Expenditure |
107.948 |
58.483 |
37.783 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
PAT / Total Income |
(%) |
1.05
|
1.81 |
1.95 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
3.34
|
4.56 |
2.98 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
2.55
|
3.73 |
1.95 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.06
|
0.10 |
0.12 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
1.49
|
2.80 |
5.41 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.60
|
1.34 |
1.30 |
LOCAL AGENCY FURTHER
INFORMATION
Form 8
|
Name of the company |
HOSPIMEDICA
INTERNATIONAL PRIVATE LIMITED |
|||||||||||||||
|
Presented By |
Mr. Sunil Anand
(Managing Director) |
|||||||||||||||
|
1) Date and description of instrument creating the change |
i) Agreement of loan
for over all limit dated 18.01.2001 ii) Agreement of
hypothecation of goods and assets dated 18.01.2001 iii) Agreement
regarding grant of individual limits within the overall limit dated
18.01.2001 |
|||||||||||||||
|
2) Amount secured by the charge/amount owing on the securities of charge |
Rs. 6.500
millions |
|||||||||||||||
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
i) First charge
on ensure current assets of the company including medical equipments. Goods
in transit, receivables of the company. ii) Equitable
mortgage of land and building situated at 58/10, Ashok Nagar, New Delhi – 18
in the name of Mrs. Meeta Anand iii) Equitable mortgage
of property situated at 4B/27, Tilak Nagar, New Delhi – 18 in the name of 5th
Sanjeev Anand iv) Equitable
mortgage of Flat at C – 3, Vireshwar Shah, Sant Janabi Road, Dixit Road Extn,
Vile Parle (East), Mumbai in the name of 5th Sunil Anand v) Assignment of
LIC policies in the name of Mr. Sunil Anand and Mrs. Meeta Anand vi).Personal
guarantee of 5th Sunil Anand, Mr. Sanjeev Anand and Mrs. Meeta
Anand |
|||||||||||||||
|
4) Gist of the terms and conditions and extent and operation of the charge. |
i) 25% margin in respect
of Bank Guarantees issued. ii) Interewst to
be charged @ 2.50% p.a. over and above SBAR minimum @ 2.75%. |
|||||||||||||||
|
5) Name and Address and description of the person entitled to the charge. |
State Bank of
India, Tilak Nagar, New Delhi –
110018, India |
|||||||||||||||
|
6) Date and brief description of instrument modifying the charge |
i) Agreement of
loan for overall limit dated 26.10.2004 ii) Agreement of
hypothecation of goods and assets dated 26.10.2004 iii) Letter regarding
grant of individual limits with in the overall limit dated 26.10.2004 |
|||||||||||||||
|
7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification. |
The extent of
operation of the charge stands enhanced from Rs. 6.500 millions to Rs. 13.500
millions due to increase in working capital limits.
Interest @ 2.50%
p.a. over and above SBAR minimum @ 12.75% margin: stocks 25%, Book Debts 30%,
Cash margin – BG 25% Other terms and
conditions remain the same. |
Export
Subject reportedly
exports its products and supplies to Hospitals and Medical Research Institutes
in India
v AFC, New Delhi
v AIIMS
v AIIPMR, Mumbai
v Akshay Natraj, Mumbai
v Alliance Pharmaceuticals, Ludhiana
v Apollo neuro Hospital, Chennai
v Apollo Indiraprastha Hospital, New Delhi
v Armed Forces Clinic
v Army Hospital, R&R, New Delhi
v Aruna Asaf Ali Govt Hospital, New Delhi
v Base Hospital, Lucknow
v Batra Hospital & Medical Research Centre
v Bhutani Medicose, New Delhi
v Bombay Hospital & Medical Research
Centre
v Bombay Hospital Trust
v Central Coalfields Ltd., Ranchi
v CGHS Medical Store Depot
v Civil Hospital, Ahmedabad
v General Hospital Chandigarh
v Institute of Physically Handicapped
v Indraprastha Medical Corporation Limited
v Institute of Communication & Cognitive
Neruo Sci
v International Park Royal
v Jadhav Neurology Centre
v JIPMER, Pondicherry
v Kalawati Saran Children Hospital
v Tata Main Hospital Jamshedpur
v Toshi Orthopaedic Centre
v
VIMHANS, New
Delhi
Trade References
v Biodex Medical System Inc., USA
v Colin Corporation, Japan
v Enaf Notius B.V., Netherlands
v H Medical, France
v Matintch Inc., USA
v Medical Educational Technologies Inc.,
v Menaara Instrumentanium Corp., Finland
v Oxford Instruments Medical System Ltd., UK
v Thermained Germany
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 42.87 |
|
UK Pound |
1 |
Rs. 83.41 |
|
Euro |
1 |
Rs. 66.11 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
4 |
|
--PROFITABILIRY |
1~10 |
4 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
4 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
43 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|